Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lung injury

Sin Yu Chen, Yi Ling Chen, Po Chen Li, Tai Shan Cheng, Yeh Shiu Chu, Yi Shan Shen, Hsin Tung Chen, Wei Ni Tsai, Chien Ling Huang, Martin Sieber, Yuan Chieh Yeh, Hsiao Sheng Liu, Chi Ling Chiang, Chih Hung Chang, Andrew S. Lee, Yen Han Tseng, Ly James Lee*, Hsiu Jung Liao*, Hon Kan Yip*, Chi Ying F. Huang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Acute lung injury (ALI) is a life-threatening respiratory condition characterized by severe inflammation and lung tissue damage, frequently causing rapid respiratory failure and long-term complications. The microRNA let-7a-5p is involved in the progression of lung injury, inflammation, and fibrosis by regulating immune cell activation and cytokine production. This study aims to use an innovative cellular electroporation platform to generate extracellular vesicles (EVs) carring let-7a-5p (EV-let-7a-5p) derived from transfected Wharton’s jelly-mesenchymal stem cells (WJ-MSCs) as a potential gene therapy for ALI. Methods: A cellular nanoporation (CNP) method was used to induce the production and release of EV-let-7a-5p from WJ-MSCs transfected with the relevant plasmid DNA. EV-let-7a-5p in the conditioned medium were isolated using a tangential flow filtration (TFF) system. EV characterization followed the minimal consensus guidelines outlined by the International Society for Extracellular Vesicles. We conducted a thorough set of therapeutic assessments, including the antifibrotic effects using a transforming growth factor beta (TGF-β)-induced cell model, the modulation effects on macrophage polarization, and the influence of EV-let-7a-5p in a rat model of hyperoxia-induced ALI. Results: The CNP platform significantly increased EV secretion from transfected WJ-MSCs, and the encapsulated let-7a-5p in engineered EVs was markedly higher than that in untreated WJ-MSCs. These EV-let-7a-5p did not influence cell proliferation and effectively mitigated the TGF-β-induced fibrotic phenotype by downregulating SMAD2/3 phosphorylation in LL29 cells. Furthermore, EV-let-7a-5p regulated M2-like macrophage activation in an inflammatory microenvironment and significantly induced interleukin (IL)-10 secretion, demonstrating their modulatory effect on inflammation. Administering EVs from untreated WJ-MSCs slightly improved lung function and increased let-7a-5p expression in plasma in the hyperoxia-induced ALI rat model. In comparison, EV-let-7a-5p significantly reduced macrophage infiltration and collagen deposition while increasing IL-10 expression, causing a substantial improvement in lung function. Conclusion: This study reveals that the use of the CNP platform to stimulate and transfect WJ-MSCs could generate an abundance of let-7a-5p-enriched EVs, which underscores the therapeutic potential in countering inflammatory responses, fibrotic activation, and hyperoxia-induced lung injury. These results provide potential avenues for developing innovative therapeutic approaches for more effective interventions in ALI.

Original languageEnglish
Article number30
JournalJournal of Biomedical Science
Volume31
Issue number1
DOIs
StatePublished - Dec 2024

Keywords

  • Acute lung injury
  • Anti-inflammation
  • Cellular nanoporation
  • Extracellular vesicles
  • Let-7a-5p
  • Mesenchymal stem cells

Fingerprint

Dive into the research topics of 'Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lung injury'. Together they form a unique fingerprint.

Cite this